Menu
2003 Session

Budget Amendments - SB700 (Committee Approved)

View Budget Item
View Budget Item amendments

Preferred Drug List

Item 325 #12s

Item 325 #12s

First Year - FY2003 Second Year - FY2004
Health And Human Resources
Medical Assistance Services, Department of FY2003 $0 FY2004 $987,070 GF
FY2003 $0 FY2004 $992,214 NGF

Language
Page 310, line 52, strike "$3,463,427,364" and insert "$3,465,406,648".
Page 322, delete lines 56 through 58.
Page 323, delete lines 1 through 23 and insert:
"ZZ. 1.  Notwithstanding §32.1-331.12 et seq. Code of Virginia, the Department of Medical Assistance Services, in consultation with the Department of Mental Health, Mental Retardation, and Substance Abuse Services, shall amend the State Plan for Medical Assistance Services to modify the delivery system of pharmaceutical products as to include a Preferred Drug List program no later than January 1, 2004.  Those pharmacy products not included on the preferred drug list will be subject to prior authorization. The final design of the program, including all operational components, must be completed no later than May 1, 2003.  In developing the modifications the Department shall consult with other interested parties including but not limited to, physicians, pharmacists, pharmaceutical manufacturers, and patient advocates.  Notwithstanding §32.1-331.12 et seq. Code of Virginia, to implement these changes the Department of Medical Assistance Services shall promulgate emergency regulations to become effective within 280 days or less from the enactment of this act. With respect to such State Plan amendment and regulations, the provisions of § 32.1-331.12 et seq. Code of Virginia shall not apply.  In addition, the Department shall work with the Department of Mental Health, Mental Retardation and Substance Abuse Services to consider utilizing a Preferred Drug List program for its non-Medicaid clients.
2.  The Department of Medical Assistance Services shall utilize a Pharmacy and Therapeutics Committee to assist in the development and ongoing administration of the Preferred Drug List program and the associated prior authorization process.  The Pharmacy and Therapeutics Committee shall be composed of twelve members, including the Commissioner of the Department of Mental Health, Mental Retardation, and Substance Abuse Services, or his designee.  The other eleven members are to be selected or approved by the Department.  Six of the members shall be physicians licensed in Virginia, one of whom is a psychiatrist and one of whom specializes in care for the aging; and five members shall be pharmacists licensed in Virginia, one of whom has clinical expertise in mental health drugs and one of whom has clinical expertise in community-based mental health treatment.
3.  The Pharmacy and Therapeutics Committee shall recommend to the Department of Medical Assistance Services (i) which therapeutic classes of drugs should be subject to the Preferred Drug List Program and the associated prior authorization process; (ii) which specific drugs within each therapeutic class should be included on the preferred drug list; and (iii) whether the Preferred Drug List Program should include reference drugs by therapeutic class and supplemental rebates.  In developing and maintaining the preferred drug list, the Pharmacy and Therapeutics Committee first shall determine which drugs are safe and clinically effective; the cost effectiveness of any given drug shall be considered only after it is determined to be safe and clinically effective.  
4.  The Preferred Drug List Program and associated prior authorization process shall not apply to atypical anti-psychotic drugs or other similar therapeutic classes used in the treatment of mental illness that have proven to be safe and clinically effective in the provision of community-based services.  The Pharmacy and Therapeutics Committee shall consider recommending the adoption of grandfather clauses when prior authorization would interfere with established drug regimens that have proven to be clincally effective."


Explanation
(This amendment authorizes the Department of Medical Assistance Services to create a Preferred Drug List for the Medicaid program to be implemented no later than January 1, 2004. A committee of qualified physicians and pharmacists to be known as the Pharmacy and Therapeutics Committee will recommend which therapeutic classes should be subject to the preferred drug list, which drugs within each therapeutic class should be included on the preferred drug list (i.e., would not be subject to prior authorization requirements), and whether the program should include reference drugs by therapeutic class and supplemental rebates. While atypical, anti-psychotic drugs are specifically excluded from the Preferred Drug List Program, other prescription drugs will also likely be excluded, for example, when prior authorization would interfere with proven drug regimens for specific illnesses (e.g., anti-virals for HIV/AIDS)).